Elo Mutual Pension Insurance Co Grows Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Elo Mutual Pension Insurance Co grew its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.7% in the second quarter, Holdings Channel reports. The firm owned 68,593 shares of the pharmacy operator’s stock after acquiring an additional 1,794 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Walgreens Boots Alliance were worth $830,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in WBA. Capital World Investors grew its stake in Walgreens Boots Alliance by 57.5% in the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after acquiring an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its position in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Walgreens Boots Alliance by 6.1% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock worth $32,882,000 after buying an additional 156,484 shares during the period. Schroder Investment Management Group lifted its holdings in shares of Walgreens Boots Alliance by 1.2% in the 4th quarter. Schroder Investment Management Group now owns 2,249,654 shares of the pharmacy operator’s stock worth $58,738,000 after buying an additional 27,634 shares during the period. Finally, Ariel Investments LLC grew its position in shares of Walgreens Boots Alliance by 25.3% during the 1st quarter. Ariel Investments LLC now owns 1,839,987 shares of the pharmacy operator’s stock worth $39,909,000 after buying an additional 371,386 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Trading Down 3.0 %

NASDAQ WBA opened at $8.71 on Friday. The company has a fifty day simple moving average of $10.29 and a two-hundred day simple moving average of $14.77. The stock has a market cap of $7.52 billion, a P/E ratio of -1.29, a P/E/G ratio of 1.02 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 12-month low of $8.46 and a 12-month high of $27.05. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.00 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were issued a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.48%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Analyst Upgrades and Downgrades

WBA has been the subject of a number of research reports. Evercore ISI lowered their price objective on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research note on Friday, June 28th. JPMorgan Chase & Co. dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Royal Bank of Canada reduced their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. TD Cowen dropped their target price on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, September 12th. Finally, UBS Group reduced their price target on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research report on Wednesday, July 3rd. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.